Abstract:An imbalance in the osteogenesis and adipogenesis of bone marrow-derived stromal cells (BMSCs) is a crucial pathological factor in the development of osteoporosis. Growing evidence suggests that extracellular nucleOtide signaling involving the P2 receptors plays a significant role in bone metabolism. The aim of the present study was to investigate the effects of uridine triphosphate (UTP) on the osteogenic and adipogenic differentiation of BMSCs, and to elucidate the underlying mechanisms. The differentiation of the BMSCs was determined by measuring the mRNA and protein expression levels of osteogenic- and adipogenic-related markers, alkaline phosphatase (ALP) staining, alizarin red staining and Oil Red O staining. The effects of UTP on BMSC differentiation were assayed using selective P2Y receptor antagonists, small interfering RNA (siRNA) and an intracellular signaling inhibitor. The incubation of the BMSCs with UTP resulted in a dose-dependent decrease in osteogenesis and an increase in adipogenesis, without affecting cell proliferation. Significantly, siRNA targeting the P2Y2 receptor prevented the effects of UTP, whereas the P2Y6 receptor antagonist (MRS2578) and siRNA targeting the P2Y4 receptor had little effect. The activation of P2Y receptors by UTP transduced to the extracellular signal-regulated kinase 1/2 (ERK1/2) signaling pathway. This transduction was prevented by the mitogen-activated protein kinase inhibitor (U0126) and siRNA targeting the P2Y2 receptor. U0126 prevented the effects of UTP on osteogenic- and adipogenic-related gene expression after 24 h of culture, as opposed to 3 to 7 days of culture. Thus, our data suggest that UTP suppresses the osteogenic and enhances the adipogenic differentiation of BMSCs by activating the P2Y2 receptor. The ERK1/2 signaling pathway mediates the early stages of this process.

Downregulation of the RNA-binding protein PUM2 facilitates MSC-driven bone regeneration and prevents OVX-induced bone loss

Circ-Plod2 Destabilizes Mpo Mrna by Binding to IGF2BP2 to Promote Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells.

Microrna-338-3p Regulates Osteogenic Differentiation of Mouse Bone Marrow Stromal Stem Cells by Targeting Runx2 and Fgfr2

TLR4 downregulation by the RNA-binding protein PUM1 alleviates cellular aging and osteoarthritis

RNA‐binding Protein PUM2 Suppresses Osteosarcoma Progression Via Partly and Competitively Binding to STARD13 3′UTR with Mirnas

p62/SQSTM1 indirectly mediates remote multipotent mesenchymal cells and rescues bone loss and bone marrow integrity in ovariectomized rats

LncRNA, PLXDC2-OT Promoted the Osteogenesis Potentials of MSCs by Inhibiting the Deacetylation Function of RBM6/SIRT7 Complex and OSX Specific Isoform

PPARgamma2 Regulates a Molecular Signature of Marrow Mesenchymal Stem Cells

Silencing Proteasome 26S Subunit ATPase 2 (PSMC2) Protects the Osteogenic Differentiation In Vitro and Osteogenesis In Vivo

LINC00963 Represses Osteogenic Differentiation of hBMSCs via the miR-10b-5p/RAP2A/AKT Axis

Mir-204 Inhibits the Osteogenic Differentiation of Mesenchymal Stem Cells by Targeting Bone Morphogenetic Protein 2

Pax2 is essential for proliferation and osteogenic differentiation of mouse mesenchymal stem cells via Runx2

Long Non-coding RNAs LOC100126784 and POM121L9P Derived from Bone Marrow Mesenchymal Stem Cells Enhance Osteogenic Differentiation Via the Mir-503-5p/sorbs1 Axis.

MicroRNA-664a-5p Promotes Osteogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells by Directly Downregulating HMGA2.

Circ_0006873 suppresses the osteogenic differentiation of human‐derived mesenchymal stem cells through mediating miR‐20a/SMURF2 axis in vitro

The RNA-Binding Protein PUM2 Impairs Mitochondrial Dynamics and Mitophagy During Aging.

Mettl3-mediated M(6)a RNA Methylation Regulates the Fate of Bone Marrow Mesenchymal Stem Cells and Osteoporosis

Downregulated microRNA-199a-3p enhances osteogenic differentiation of bone marrow mesenchymal stem cells by targeting Kdm3a in ovariectomized rats

The RNA-binding protein Musashi2 governs osteoblast-adipocyte lineage commitment by suppressing PPARγ signaling

MicroRNA‑92a Overexpression Promotes the Osteogenic Differentiation of Bone Mesenchymal Stem Cells by Impeding Smad6‑mediated Runt‑related Transcription Factor 2 Degradation

Regulation of the Osteogenic and Adipogenic Differentiation of Bone Marrow-Derived Stromal Cells by Extracellular Uridine Triphosphate: the Role of P2y2 Receptor and Erk1/2 Signaling